Narrow Your Search

Narrow Your Search

Focus

Companies

People

News

11,551 News Articles
May
12
2025

Molecular approach prolongs ketamine's antidepressant effects in mice by weeks

Researchers at Vanderbilt University identified a molecular approach to extend the antidepressant effects of ketamine in mice by applying BCI, ...
May
12
2025

PRISM MarketView Honors Mental Health Awareness Month with - GlobeNewswire

Psychedelics, such as psilocybin and MDMA, are showing promising results in treating mental health conditions like depression, PTSD, and anxiety.
May
12
2025

Clinicians Invited To Explore Breakthroughs In Psychedelics At PS2025 - Forbes

Psychedelic Science 2025 is inviting trauma therapists and other mental health professionals to attend its upcoming conference, which is designed ...
Psychedelics Psilocybin
May
08
2025

Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy

1000 GMP doses of MDMA now reaching patients with PTSD under Australia's Authorised Prescriber Scheme; Department of Veterans' Affairs to fund ...
MDMA
May
08
2025

Texas House Approves Bills To Speed Access To Psychedelic-Assisted Therapies ...

... psychedelics—specifically MDMA, psilocybin and ketamine—as a treatment PTSD, depression and other mental health disorders. Officials would also ...
May
08
2025

Psilocybin in Serious Illness: James Downar, Ali John Zarrabi and Margaret Ross - GeriPal

In today's episode, we're taking a closer look at the current state of the science around one specific psychedelic: psilocybin. We'll discuss three ...
May
08
2025

A dose of psilocybin stirred the brain of a barely conscious woman - MSN

A new case report published in Clinical Neurophysiology describes the first known administration of psilocybin—a psychedelic compound found in ...
May
08
2025

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

COMP360 psilocybin treatment in TRD (Treatment Resistant Depression). The pivotal phase 3 clinical program of COMP360 psilocybin treatment in TRD ...
May
08
2025

psychedelics Archives | A Geriatrics and Palliative Care Podcast for Every Healthcare Professional

We've covered psychedelics on the podcast before—first in 2019 with Ira Byock, where we explored their potential role in medicine,…
May
08
2025

Magic mushrooms may boost mood and brain health for Parkinson's disease patients, study reveals

In the first psychedelic study tested on neurodegenerative disease patients, researchers have discovered that psilocybin therapy elicits meaningful ...
May
08
2025

Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy

n Optimi Health (OPTHF) successfully exports 1000 GMP-certified MDMA capsules to Australia for PTSD treatment. Australian Department of Veterans' ...
MDMA
May
08
2025

Using MDMA to face my trauma was healing, vivid — and a bit banal - Toronto Star

She found someone with a substance first derived from the oil of the sassafras tree: MDMA, a drug said to have potential for treating PTSD. She ...
MDMA
May
08
2025

COMPASS Pathways plc SEC 10-Q Report - TradingView

Research and Development Focus: The company is focused on developing its investigational COMP360 psilocybin treatment, particularly for treatment- ...
May
07
2025

Psilocybin-Assisted Therapy Market, Revolutionizing Mental - openPR.com

Press release - Persistence Market Research - Psilocybin-Assisted Therapy Market, Revolutionizing Mental Health Treatment with Breakthrough ...
May
07
2025

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor ...

Status of the New Drug Application (NDA) for NRX-100 (preservative-free IV Ketamine), following FDA's grant of a $4.3 million filing fee waiver ...
May
07
2025

Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin ...

Psilocybin is an emerging intervention for depression that may be at least as effective as selective serotonin reuptake inhibitors (SSRIs), ...
Psilocybin
May
07
2025

Advocates see hope in Iowa psilocybin legislation | Tri-state News | telegraphherald.com

Psilocybin is a naturally occurring psychedelic compound found in various species of mushrooms.
Psilocybin
May
07
2025

The One Thing That Matters Most When Starting Psychedelic 'Microdosing' Therapy

Microdosing psychedelics, typically with psilocybin, the active compound in “magic mushrooms,” has become an increasingly popular approach for ...
May
05
2025

NRx Pharmaceuticals seeks patent for preservative-free ketamine - Investing.com

... ketamine formulation aimed at treating suicidal depression. The application, if approved, could extend NRX-100's market exclusivity until 2045 ...
May
05
2025

Optimi Health Secures U.S. FDA Registration for Psychedelic Drug Supply - TipRanks.com

... psychedelic-assisted therapies. The registration enables Optimi to engage in FDA filings, supply U.S. distributors, and file Abbreviated New Drug ...
May
05
2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100 ... - PR Newswire

... ketamine; Filing strengthens NRx's leadership in advancing safe and ... ketamine formulation for the treatment of suicidal depression. The ...
May
05
2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Patent Application for NRX-100, its ... - GuruFocus

n NRx Pharmaceuticals (NRXP) files a patent application for NRX-100, a preservative-free IV ketamine formulation. The patent, if granted, ...
May
05
2025

Optimi Health Obtains U.S. FDA Drug Establishment Registration - Yahoo Finance

... psychedelic-assisted therapies. ... This milestone brings us one step closer to our goal of delivering cost-effective, GMP psychedelics at scale.
MDMA
May
05
2025

Archaeologists Unearth 2000-Year-Old Evidence of Psychedelic Use by This Enigmatic ...

Archaeologists Unearth 2000-Year-Old Evidence of Psychedelic Use by This Enigmatic Ancient Culture ... New research is revealing how hallucinogens ...
May
05
2025

Microdosing psychedelics studied | Press Enterprise Online

Microdosing psychedelics studied. By Carla K. Johnson - AP Medical Writer. Published: May 5, 2025. Microdosing is gaining popularity with a new breed ...
May
05
2025

Optimi Health Obtains U.S. FDA Drug Establishment Registration - Stock Titan

This development is particularly timely as 25 U.S. states have considered psychedelic legislation through more than 74 bills.
MDMA
May
05
2025

Emerging Efforts to Expand Access to Psilocybin Therapy: A Critical Opportunity for ...

As evidence grows for psilocybin-assisted therapy's effectiveness in treating mental health and addiction, efforts are increasingly focused on ...
Psilocybin
May
05
2025

Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman as Strategic Advisor

... psilocybin products. As the world's inaugural legal exporter of psilocybin, Rose Hill is dedicated to advancing scientific research, expanding ...
May
05
2025

NRx Pharmaceuticals (NRXP) Files Patent Application for NRX-100 - StreetInsider

... ketamine formulation for the treatment of suicidal depression. The application discloses pharmaceutical compositions, methods of treatment and ...
May
02
2025

Pα+ Psychedelic Bulletin #195: Psychedelics Namechecked in Trump Cabinet Meeting

Psychedelics Namechecked in Trump Cabinet Meeting • Noma Therapy Raises $4.25M, Aims to Disrupt At-Home Ketamine With Insurance-Friendly Approach ...
Ketamine Psychedelics
May
02
2025

See inside PAX, a ketamine therapy clinic in Sioux Falls - Argus Leader

The team at PAX Institute uses ketamine therapy to treat depression.
May
02
2025

You're not hallucinating: Indiana's legislature is funding psilocybin research | Opinion

Of all the things Indiana is known for — basketball, the Indy 500, limestone, medical devices, political inertia and more basketball — being a ...
May
02
2025

Ketamine Treatment is Effective in Treating Restrictive Anorexia Nervosa

Ketamine Adjuvant Treatment (KAT) is associated with significant improvements in BMI and reductions in cognitive rigidity among patients with ...
Ketamine
May
02
2025

FDA's Tarver says agency open to improvement of third-party reviews | BioWorld

MDMA President/CEO Mark Leahey observed that reviewers at the FDA's Office of Product Evaluation and Quality (OPEQ) were more inclined to revisit ...
MDMA
May
02
2025

How a Sioux Falls clinic is using ketamine to treat depression - Argus Leader

PAX Institute combines ketamine infusions with guided therapy sessions for a comprehensive approach. What if there's another way? May is Mental Health ...
May
01
2025

LSD analogue synthesised by swapping just two atoms less likely to cause hallucinations

... psychedelic analogues in the treatment of neuropsychiatric diseases such as schizophrenia, where the use of psychedelics is not recommended. LSD ...
LSD